Atnaujintas knygų su minimaliais defektais pasiūlymas! Naršykite ČIA >>

The Comparative Impact of Globalization of Clinical Trials in India and China

-15% su kodu: ENG15
42,81 
Įprasta kaina: 50,36 
-15% su kodu: ENG15
Kupono kodas: ENG15
Akcija baigiasi: 2025-03-03
-15% su kodu: ENG15
42,81 
Įprasta kaina: 50,36 
-15% su kodu: ENG15
Kupono kodas: ENG15
Akcija baigiasi: 2025-03-03
-15% su kodu: ENG15
2025-02-28 50.3600 InStock
Nemokamas pristatymas į paštomatus per 11-15 darbo dienų užsakymams nuo 20,00 

Knygos aprašymas

Master's Thesis from the year 2013 in the subject Medicine - Hospital Environment, Clinical Medicine, Walden University, course: Clinical Research and Administration- General concentration, language: English, abstract: India and China have been identified by pharmaceutical companies as the future markets that would support drug research and development in a cost efficient manner. This has become necessary as resources to conduct clinical studies dwindle, coupled with the fact that pharmaceutical industries are under pressure to deliver quality medicine, on time, to the public. Exploring and examining India and Chinäs potential in a stepwise fashion provides the opportunity to dissect the good, the bad and the ugly of globalization in a comparative approach. This paper will cover areas like ethics in the conduct of studies, good clinical practice (GCP), economic realities, ICH influence, intellectual property security and the role of government in global clinical trial.

Informacija

Autorius: Ginika Egesimba
Leidėjas: GRIN Publishing
Išleidimo metai: 2013
Knygos puslapių skaičius: 36
ISBN-10: 3656424144
ISBN-13: 9783656424147
Formatas: 210 x 148 x 4 mm. Knyga minkštu viršeliu
Kalba: Anglų

Pirkėjų atsiliepimai

Parašykite atsiliepimą apie „The Comparative Impact of Globalization of Clinical Trials in India and China“

Būtina įvertinti prekę